3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
57
Pancreatic Neoplasms
39
Carcinoma, Non-Small-Cell Lung
29
Triple Negative Breast Neoplasms
20
Neoplasms
17
Neoplasm Metastasis
11
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Ovarian Neoplasms
8
Melanoma
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Adenocarcinoma
6
Urinary Bladder Neoplasms
5
Inflammatory Breast Neoplasms
5
Carcinoma
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Diseases
4
Fallopian Tube Neoplasms
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Pancreatic Adenocarcinoma
3
Esophageal Neoplasms
3
Endocrine System Diseases
3
Endocrine Gland Neoplasms
3
Digestive System Neoplasms
3
Digestive System Diseases
3
Interventions
mogamulizumab
3
Cyclophosphamide
3
Lenalidomide
2
Alemtuzumab
2
ruxolitinib
1
peginterferon alfa-2b
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
denileukin diftitox
1
belinostat
1
Zidovudine
1
Vincristine
1
Raltegravir Potassium
1
Prednisone
1
Oxaliplatin
1
Introns
1
Interleukin-15
1
Gemcitabine
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Daclizumab
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Bortezomib
1
B3(Fv)-PE38KDEL recombinant immunotoxin
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia-Lymphoma, Adult T-Cell
×
Albumin-Bound Paclitaxel
×
Clear all
No trials found.